BIOSeedin Winter Innovation Partnering Summit: J.P.Morgan Spotlight
SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- As a spotlight event of J.P. Morgan Healthcare Week, BIOSeedin Winter Innovation Partnering Summit...
Read moreDetails
Uncategorized
Alrajhi Medicine to Digitize its Healthcare Operations with Oracle to Foster Better Patient and Staff Experiences
Adopts Oracle Health Foundation EHR and Oracle Fusion Cloud Applications to increase efficiency and drive growthAUSTIN, Texas, Jan. 27, 2026...
Read moreDetailsSecuritas AB to publish the Full-Year Report January-December 2025 on February 4, 2026
STOCKHOLM, Jan. 27, 2026 /PRNewswire/ -- Securitas AB will publish the Full-Year Report January-December 2025 on Wednesday February 4, 2026, at...
Read moreDetailsCurrent geopolitical tensions are putting pressure on the internal security of European organisations
84% of European high-risk profile organisations do not feel well equipped to detect and handle insider incidents, according to the...
Read moreDetailsJanus Henderson GCC Bonds – Net Asset Value(s)
Janus Henderson GCC Sovereign USD Bond Core UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since...
Read moreDetailsJanus Henderson US ENH Inf E GBP – Net Asset Value(s)
Janus Henderson US Enhanced Inflation Core UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous...
Read moreDetailsHexaware is the Second-Fastest-Growing Indian IT Services Brand by Brand Value
LONDON, Jan. 27, 2026 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a global provider of IT solutions and services, today announced...
Read moreDetailsJanus Henderson US ENH Inf E$ – Net Asset Value(s)
Janus Henderson US Enhanced Inflation Core UCITS ETF Valuation Date ISIN Code Shares in Issue Currency Share Redeemed since Previous...
Read moreDetailsAsthma and Allergy Drug Development Is Failing Too Often–A Translational Reset Is Needed: HKEY-AIRx™1.0
BOSTON and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug...
Read moreDetailsLibevitug Approved in China as First-in-Class Hepatitis D Treatment
BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval...
Read moreDetails